[HTML][HTML] Neuroleptic malignant syndrome: a neuroimmunologic hypothesis

RE Anglin, PI Rosebush, MF Mazurek - Cmaj, 2010 - Can Med Assoc
DOI: 10.1503/cm aj. 091442 decreased gluconeogenesis, increased lipogenesis and
lipolysis to cachexia, muscle breakdown and osteoporosis. The classic biochemical profile …

Neuroleptic malignant syndrome: a review

AL Pelonero, JL Levenson… - Psychiatric …, 1998 - Am Psychiatric Assoc
OBJECTIVE: Neuroleptic malignant syndrome is an uncommon side effect of antipsychotic
medications characterized by severe rigidity, tremor, fever, altered mental status, autonomic …

Neuroleptic malignant syndrome: An underdiagnosed reaction to neuroleptic agents?

CJ Lavie, TR Olmsted, HO Ventura… - Postgraduate …, 1986 - Taylor & Francis
Preview The neuroleptic malignant syndrome (NMS) is an idiosyncratic reaction to
neuroleptic agents that consists of fever, mental status changes, muscle rigidity, autonomic …

Neuroleptic malignant syndrome: an easily overlooked neurologic emergency

R Oruch, IF Pryme, BA Engelsen… - … disease and treatment, 2017 - Taylor & Francis
Neuroleptic malignant syndrome is an unpredictable iatrogenic neurologic emergency
condition, mainly arising as an idiosyncratic reaction to antipsychotic agent use. It is …

[HTML][HTML] Resolution of symptoms in neuroleptic malignant syndrome

YDS Pereira, A Srivastava… - Indian Journal of …, 2010 - journals.lww.com
Although neuroleptic malignant syndrome (NMS) manifests consistently with hyperthermia,
muscle rigidity, altered mental state, and autonomic instability, heterogeneity exists in the …

Neuroleptic malignant syndrome: complications, outcomes, and mortality

S Modi, D Dharaiya, L Schultz, P Varelas - Neurocritical care, 2016 - Springer
Objective Our study objective was to identify real-world rates of complications, mortality, and
outcomes in patients with neuroleptic malignant syndrome (NMS) over the last decade in the …

Neuroleptic malignant syndrome in trauma patient

A Gragnani, MVB Cezillo, AF Oliveira, LM Ferreira - Burns, 2015 - Elsevier
In recent years, there has been an increased use of neuroleptic agents in the unit care in
trauma patients. There is a lack of prospective data, and most of the information is obtained …

Progression of symptoms in neuroleptic malignant syndrome

VR Velamoor, RMG NORMAN, SN Caroff… - The Journal of …, 1994 - journals.lww.com
The neuroleptic malignant syndrome (NMS) is a rare but potentially fatal disorder
characterized by mental-status changes, muscle rigidity, hyperthermia, and autonomic …

Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS

MD Andreassen, S Pedersen - Ugeskrift for laeger, 2000 - europepmc.org
Neuroleptic malignant syndrome (NMS) is a rare, potentially life-threatening disorder that
results from the use of neuroleptics. NMS was first recognised as a complication of …

Early recognition of neuroleptic malignant syndrome during traumatic brain injury rehabilitation

V Kadyan, SC Colachis, MJ Depalma, JD Sanderson… - Brain Injury, 2003 - Taylor & Francis
Neuroleptic malignant syndrome is a rare disorder that manifests with hyperthermia, muscle
rigidity and autonomic instability. Presented is a case series of individuals with traumatic …